01 May Black Woman Scientist Files Patent For Coronavirus Treatment
Darnisha Harrison, founder and CEO of Ennaid Therapeutics, says that scientists working for her company have found a drug that is showing promise in laboratories at blocking the continued spread of COVID-19. Based in Atlanta, Georgia, her company uses its artificial intelligence (AI)-based drug discovery platforms to develop anti-viral drugs.
Both BET News and WBRZ-TV, an ABC News affiliate in Baton Rouge, have confirmed that Harrison, who graduated from Louisiana State University, has already filed a patent after discovering a drug that shows strong scientific evidence of blocking two proteins that cause COVID-19 from invading healthy host cells and replicating.
The drug is called ENU200, a repurposed, patent-pending, orally deliverable antiviral drug that was previously approved by the U.S. Food and Drug Administration (FDA) for a different indication.
To read the rest of the article HERE
Sorry, the comment form is closed at this time.